While it has been widely appreciated that myocardial function is increased with optimal digitalis dosage, it is not well recognized that toxic concentration may impair myocardial efficiency to the point of producing increased signs and symptoms of congestive heart failure. This was (lemonstrated in 15 patients who could be adequately maintained with a digitalis preparation. Upon increase in dosage, all patients presented an increase in congestive heart failure which subsi(led upon stopping or decreasing the digitalis dosage.
IN THE treatment of chronic congestive
heart failure an attempt is made to establish the optimum maintenance dose of digitalis or any of the cardiac glycosides in order to achieve the maximum possible muscular efficiency of heart muscle. It is well recognized that a patient not receiving sufficient digitalis will manifest varying degrees of impaired cardiac reserve. On the other hand, it has not been appreciated that overdosage of digitalis may also result in lessened myocardial efficiency. It is the purpose of this report to present evidence that congestive heart failure may occur secondary to digitalis intoxication.
During our studies1 on the evaluation of digitalis-leaf preparations and the various glycosides for the management of the ambulatory patient with congestive heart failure this phenomenon brought itself to our attention. In every patient we attempted to determine for each individual glycoside and digitalis-leaf preparation the therapeutic range. This consisted of first ascertaining the minimal daily dose for satisfactory maintenance and then, at eightto twelve-week intervals, increasing by small increments the daily dose of the preparation being investigated until the earliest detectable signs and symptoms of toxicity supervened.
A total of 93 patients was included in this study. None of these patients manifested any From of the signs or symptoms of congestive heart failure when the optimum dose of a digitalis preparation was administered; and furthermore, as long as this optimum dose was continued, none required any diuretic agent or other adjuvant therapy. All of the patients were unrestricted as to diet throughout the period of observation. None of the patients presented any evidence of a complication of their heart disease such as rheumatic activity, myocardial infarction, or any other precipitating factor which could possibly have accounted for the noted decreased efficiency of heart muscle.
During this investigation, we had the opportunity to evaluate various lots of digitalis leaf, digoxin, digitoxin, lanatoside C, urginin maritima, urginin indica, and gitalin. In this group of 93 patients there were 233 manifestations of minimal toxicity. Fifteen of these patients presented sixteen episodes of increasing signs and symptoms of congestive heart failure when the dose level of the digitalis preparation in question reached the toxic range. Every patient exhibited, in addition to the syndrome of congestive failure, one or more of the accepted manifestations of digitalis intoxication, such as anorexia, nausea, vomiting, epigastric distress and pain, visual disturbances, headache, vertigo, precordial pain, palpitations, lethargy, fatigue, weakness, nervousness, neuralgias, insomnia, and premature systoles.
It must be emphasized that these patients were entirely free of any manifest signs or symptoms of congestive heart failure when being maintained on their optimum dose of a 1052 digitalis preparation; and that following the toxic episode, when the particular preparation was completely discontinued or reduced to optimum or suboptimum levels, the various signs and symptoms of congestive heart failure subsided along with the other well-known evidences of digitalis toxicity.
A summary of the protocols of these fifteen patients is presented in table 1. Case histories of several of them are given in greater detail below.
CASE HISTORIES Case 2.-K. C. is a 55 year old white single woman who first noted the onset of diminished cardiac reserve in 1943 with the gradual occurrence of dyspnea and fatigue. Since that time digitalis preparations had been prescribed irregularly. In September, 1947, the patient developed edema of the legs and entered Bellevue Hospital where the diagnosis of arteriosclerotic heart disease with cardiac enlargement and auricular fibrillation was made. At that time, all attempts to arrive at the cause of the hepatosplenomegaly which was present failed and it was classed as undetermined. Since that hospitalization, she has been successfully maintained without manifest signs of congestive heart failure on an ambulatory status on 0.1 Gm. of digitalis leaf or an equivalent dose of a glycoside. On February 5, 1948, after having taken 0.2 Gm. of digitalis leaf for the previous five weeks, she presented herself at the clinic with marked weakness, increased lethargy, and fatigue. The ventricular rate was 52 beats per minute with runs of coupled rhythm. There were also dyspnea, bilateral basal moist rales, and minimal pretibial edema, which were not present previously. Digitalis was withheld for three days and then the patient was instructed to take 0.1 Gm. daily. At the end of three weeks, during which period the patient remained ambulatory, there was much less dyspnea and weakness, the lungs were clear and the legs free of edema, and the weight had dropped six pounds. The electrocardiogram revealed an occasional ventricular premature systole. Case 6. N. T. is a 48 year old married white woman with a history of acute polyarthritis in 1920 at the age of 20 years. When she first came under our observation in 1940, physical examination revealed systolic and diastolic murmurs both at the apex and base, a systolic thrill at the aortic area, a pulsating liver, and a totally irregular rhythm; fluoroscopy gave evidence of generalized cardiac chamber enlargement. The diagnosis was made of rheumatic heart disease, enlarged heart wenith mitral and aortic insufficiency and stenosis, tricuspid insufficiency, and auricular fibrillation. Digitalis therapy was instituted because of the onset of dyspnea, orthopnea, fatigue, edema, and palpitations, and was by itself sufficient to maintain the patient in good compensation. On September 16, 1941, the patient came to the clinic, having taken 0.1 and 0.2 Gm. of digitalis leaf on alternate days for the previous three weeks, complaining of insomnia, increased dyspnea, and edema. A weight gain of 71 pounds was noted. Because the dose of digitalis was thought to be inadequate, she was placed on 0.2 Gm. of digitalis leaf daily and instructed to return to the clinic in three weeks and to remain ambulant. However, she presented herself one week later with anorexia, nausea, vomiting, visual disturbances, insomnia, palpitations, progressive dyspnea and edema, and signs of minimal ascites and an enlarging liver. Digitalis was stopped for three days and then 0.1 Gm. prescribed daily. One week later the signs of toxicity had disappeared and those of congestive failure were markedly improved. There was also a 54-pound weight loss. A subsequent second trial on 0.1 and 0.2 Gm. on alternate days produced anorexia, nausea, vomiting, yellow vision, palpitations, precordial pain, and weight gain after ten days' administration. This proved that this last dosage was definitely in the toxic range for this patient.
Case 12 
INCREASING CONGESTIVE HEART FAILURE
DISCUSSION-Regardless of the mechanism for congestive heart failure, whether forward or backward, all investigators are in accord that the fundamental defect is one of impaired muscular efficiency of the heart with the consequent decrease in the amount of work which it is capable of performing. Furthermore, although the exact mode of action of digitalis and its preparations for improving congestive heart failure has not yet been established, there is pharmacologic as well as clinical evidence which would indicate that a direct effect on cardiac muscle plays a role in digitalis action. Such evidence is seen in the increased efficiency of the papillary muscle of the cat. Cattell and Gold2 stimulated the isolated muscle before and after the application of ouabain and digitoxin in concentrations which were comparable to therapeutic doses in man, and noted an increase in the systolic force of contraction. Kabat and Visscher3 in their study on the influence of K-strophanthosid upon the tortoise ventricle showed that the work capacity of the myocardium was increased with optimal glycoside levels. This was primarily an effect upon contractility and unrelated to so-called muscular elasticity or tonus. Observations in the failing heart-lung preparation and in patients in congestive heart failure have demonstrated an increased cardiac output following digitalis administration, which increase is presumably largely due to an enhanced contractility, although many variables affecting cardiac output are also involved.
Experimental evidence either in the animal or the clinical use of digitalis preparations would indicate that the maximum efficiency of heart muscle function is related to optimum dosage which must be determined specifically for each experimental procedure or individual patient. Exceeding this optimum dosage results in a progressive decrease in myocardial efficiency which can be interpreted as representing a toxic influence of digitalis or its various preparations. Thus, Cattell and Gold2 and Kabat and Visscher3 found that when this optimum concentration was surpassed and toxic ranges entered, the contractility of the papillary mus-cle and tortoise ventricle, respectively, decreased and the work done was reduced.
Although this phenomenon was not appreciated clinically heretofore, several investigators reported observations which could be interpreted as clinical evidence of impaired myocardial efficiency. Thus, Mackenzie4 and Windle5 each reported 2 patients in whom pulsus alternans, a sign of disturbed myocardial contractility, occurred during the administration of a digitalis preparation. Except for one of Mackenzie's patients, the remaining 3 patients received toxic doses of the tincture of digitalis and presented pulsus alternans associated with other signs and symptoms of overdosage. It is of interest that one of Windle's patients was a 35 year old woman with functional heart disease without cardiac enlargement. However, the fact that frank signs and symptoms of congestive heart failure could be produced by overdosage of digitalis products was not readily appreciated. Our study would indicate that above the optimum dose required for proper digitalization the patient, in addition to exhibiting the classical manifestations of digitalis intoxication, may present increasing signs and symptoms of congestive heart failure. Although none of the patients in this report presented congestive failure as the only indication of digitalis toxicity, there is no correlation between the severity of the classic toxic signs and the advent of impaired myocardial efficiency. In other words, it is conceivable on a purely pharmacologic basis where all the effects of digitalis upon cardiac physiologic functions may be independent of one another, that in some patients this effect upon contractility may be the predominant action. In this situation, congestive heart failure might occur in the absence of the other well-accepted evidences of toxicity.
On an experimental basis in these 15 ambulatory patients, there was no difficulty in demonstrating that congestive heart failure occurred with digitalis toxicity. In all cases, elimination or reduction in dosage of the digitalis preparation resulted in an improvement in myocardial efficiency with subsequent satisfactory maintenance without signs and symptoms of diminished cardiac reserve. However, 1058 ROBERT C. BATTERMIAN AND LEONARD B. GUTNER patients frequently first come under observation in severe congestive failure in whom there is a history of having taken a dose of a digitalis preparation which on the basis of predictability would be a toxic dose. Clear-cut evidence of digitalis intoxication is not available in these patients since vague gastrointestinal symptoms mav be related either to visceral congestion or to toxicity. It is our feeling that many of these patients are truly toxic and that the rational regimen of therapy should be to discontinue digitalis and the patient evaluated further on bed rest alone before instituting other therapeutic measures.
SUMMARY Fifteen patients presenting sixteen episodes of increasing congestive heart failure as a manifestation of digitalis toxicity are reported.
It is believed that the syndrome of congestive heart failure as a toxic sign is the result of a direct muscular action with the consequent decrease in myocardial efficiency.
